Head-to-head
Henry Meds vs Fridays
Compared on semaglutide across the eight dimensions this database records. They differ on 5 of those eight. Fridays is cheaper on all-in semaglutide at 2.4 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Henry Meds is $297 a month all-in for semaglutide; Fridays is $175. Over twelve months that is $3,564 against $2,100. Value Scores are 60.4 and 79.3 out of 100.
Semaglutide
Plan pages: Henry Meds plans · Fridays plans
At 2.4 mg/week, Henry Meds is $297 a month all-in and Fridays is $175 — $122 apart, or $1,464 across a year. Over twelve months the totals are $3,564 (billed monthly) and $2,100 (billed monthly).
Henry Meds charges a flat $297 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Fridays charges a flat $175 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
| Dose | Henry Meds | Rank | Fridays | Rank | Cheaper |
|---|---|---|---|---|---|
| 0.25 mg | $297 | 25/32 | $175 | 11/32 | Fridays by $122 |
| 0.5 mg | $297 | 16/21 | $175 | 7/21 | Fridays by $122 |
| 1 mg | $297 | 16/21 | $175 | 7/21 | Fridays by $122 |
| 1.7 mg | $297 | 16/21 | $175 | 7/21 | Fridays by $122 |
| 2.4 mg | $297 | 22/29 | $175 | 9/29 | Fridays by $122 |
Fridays is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 29 programs this database can rank on semaglutide, Henry Meds sits 20 of 29 on all-in monthly cost and Fridays sits 7. There are 12 other programs priced between them. The field median is $249 and the floor is $129, so Fridays is below the median and the other is above it. Henry Meds is $168 above the cheapest semaglutide program on record. Fridays is $46 above the cheapest semaglutide program on record.
NovoCare Pharmacy (Wegovy), the lowest FDA-approved semaglutide channel here, is $349 a month — Henry Meds undercuts it by $52, Fridays by $174. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Henry Meds | Fridays | Cheaper |
|---|---|---|---|
| Month to month | $297 | $175 | Fridays by $122 |
| Settled dose | Henry Meds | Fridays | Difference |
|---|---|---|---|
| 0.25 mg | $3,564 | $2,100 | $1,464 apart |
| 0.5 mg | $3,564 | $2,100 | $1,464 apart |
| 1 mg | $3,564 | $2,100 | $1,464 apart |
| 1.7 mg | $3,564 | $2,100 | $1,464 apart |
| 2.4 mg | $3,564 | $2,100 | $1,464 apart |
Henry Meds publishes no rate for 3-month term, 6-month term, 12-month term; Fridays publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 2.4 mg/week, the first twelve months work out to $3,564 on Henry Meds and $2,100 on Fridays. Both programs charge one flat rate, so the ramp costs the same as any other stretch of the year.
Value Scores are 60.4 for Henry Meds and 79.3 for Fridays, against a semaglutide category floor of $129. Fridays leads by 18.9 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Henry Meds | 30.4 | 15.0 | 10 | 5 | 60.4 |
| Fridays | 51.6 | 12.8 | 10 | 5 | 79.3 |
Where the two programs differ
All-in monthly
Fridays is cheaper month to month — $175 against $297, a gap of $122 every month, or $1,464 across a year if both rates hold.
Cancellation terms
Cancellation differs: Henry Meds states Cancel before renewal; bundle refunds limited, while Fridays states Cancel before renewal. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
Henry Meds asks for Month-to-month; 6/12-month bundles prepaid; Fridays asks for Month-to-month. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Evidence status
The two prices are not equally well evidenced. Henry Meds's figure is verified and Fridays's is provider-stated. Henry Meds rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Twelve-month cost
Over twelve months the totals are $3,564 for Henry Meds and $2,100 for Fridays. Fridays is lower by $1,464 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Dose policy
Both hold one price across the whole dose ladder, so neither punishes titration and the monthly figures above are what you actually pay at 15 mg as well as at 2.5 mg.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
Henry Meds Official site
Henry Meds sells compounded semaglutide by injection at $297 per month, checkout-verified, and does not sell injectable tirzepatide at all — its tirzepatide is an oral dissolving tablet sold only as a $1,047 three-month supply, with no month-to-month rate published. The widely-quoted $179 figure applies to liraglutide or to the twelve-month prepaid term, not to a standing monthly tirzepatide rate.
It names its compounding pharmacy — Tailor Made Compounding, recorded as 503A (named on dispensed materials) — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are Month-to-month; 6/12-month bundles prepaid; cancellation is Cancel before renewal; bundle refunds limited; availability is stated as Most US states.
Evidence: verified — captured at checkout by our desk on the stated date, captured . Source — Checkout capture 2026-08-11: $297/month all-in, dispensed by Tailor Made Compounding. Supersedes our prior $179–$297 plan-tier range.
Watch: Corrected 2026-08-11. Our prior record showed $179/mo flat injectable tirzepatide, taken from two third-party 2026 captures. Direct verification found no injectable tirzepatide product. Henry is therefore unrankable on the tirzepatide injection-maintenance basis — an oral dissolving tablet is a different delivery route and is not scored against injectables. The semaglutide figure was corrected upward to $297 and is now checkout-verified.
Fridays Official site
Fridays runs flat no-membership pricing: $175/month semaglutide, $359/month tirzepatide.
It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel before renewal; availability is stated as Most US states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — joinfridays.com pricing capture 2026-08-05
Watch: Provider-stated; checkout capture pending.
Which molecules each one carries
Henry Meds carries semaglutide at $297 a month; lists tirzepatide (oral dissolving tablet (no injectable tirzepatide offered)) but publishes nothing rankable for it.
Fridays carries tirzepatide at $359 a month and semaglutide at $175 a month.
Comparable only on semaglutide: they do not both publish a rankable tirzepatide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
Henry Meds does not publish
- no published twelve-month semaglutide rate
- no state-by-state availability list — it says Most US states
Fridays does not publish
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Most US states
Ask Henry Meds and Fridays for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Neither program publishes a promotional rate with an end date, a prepaid term, or a price we have flagged for re-verification, so the comparison above is as stable as this dataset gets.
Which one suits which reader
On the lowest standing monthly rate for semaglutide, Fridays Official site wins this matchup. And if you would rather trust a better-evidenced number, henry meds's price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. Henry Meds's semaglutide price is verified as of 2026-08-11; Fridays's is provider-stated as of 2026-08-05.
Questions
Is Henry Meds or Fridays cheaper for semaglutide?
Fridays is cheaper on all-in monthly cost at 2.4 mg/week: $175 against $297, a difference of $122 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Henry Meds versus Fridays?
Henry Meds works out to $3,564 across twelve months and Fridays to $2,100, on the plan terms each publishes.
Does Henry Meds or Fridays raise the price as the dose goes up?
Henry Meds: no, it charges one flat rate at every dose. Fridays: no, it charges one flat rate at every dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Henry Meds and Fridays differ?
5 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Henry Meds and Fridays names its pharmacy?
Henry Meds does — Tailor Made Compounding. Fridays does not, recording only Partner pharmacies, so who makes its medication cannot be independently verified.
How well evidenced are the Henry Meds and Fridays prices?
Henry Meds's semaglutide figure is verified — captured at checkout by our desk on the stated date — captured 2026-08-11. Fridays's is provider-stated, captured 2026-08-05. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: Henry Meds official site · Fridays official site. Compounded tirzepatide and semaglutide are not FDA-approved products.